CSS LLC’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

CSS LLC’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-57,887	Closed	-$575K	–	1399
2021 Q3	$575K	Sell	57,887 -157,413	-73%	-$1.56M	0.02%	606
2021 Q2	$2.13M	Buy	+215,300	New	+$2.11M	0.09%	242

Other funds holding PEAR

Temasek Holdings

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

SB Global Advisers London, United Kingdom $861M AUM 71.72% 1-Year Est. Return

Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return

TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return

Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CSS LLC's PEAR Position: Q4 2021 in Review

CSS LLC sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q4 2021, closing a stake of 57,887 shares — an estimated $575K sold.

CSS LLC first reported a position in PEAR in Q2 2021 and held it in 2 quarters. The position peaked at $2.13M in Q2 2021. 25 funds tracked by Wall St. Rank hold PEAR as of Q4 2021.

CSS LLC reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
CSS LLC sold 57,887 Pear Therapeutics, Inc. Class A Common Stock shares in Q4 2021, an estimated $575K.
CSS LLC first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q2 2021 and held it in 2 quarters.
CSS LLC's Pear Therapeutics, Inc. Class A Common Stock position peaked at $2.13M in Q2 2021.
25 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q4 2021.

Based on CSS LLC's 13F filing for Q4 2021, filed 14 Feb 2022.